Predicting recurrence patterns after resection of hepatocellular cancer.

BACKGROUND The reliable prediction of hepatocellular carcinoma (HCC) recurrence patterns potentially allows for the prioritization of patients for liver resection (LR) or transplantation. OBJECTIVES The aim of this study was to analyse clinicopathological factors and preoperative Milan criteria (MC) status in predicting patterns of HCC recurrence. METHODS During 1992-2012, 320 patients undergoing LR for HCC were categorized preoperatively as being within or beyond the MC, as were recurrences. RESULTS After a median follow-up of 47 months, 183 patients developed recurrence, giving a 5-year cumulative incidence of recurrence of 62.5%. Patients with preoperative disease within the MC had better survival outcomes than those with preoperative disease beyond the MC (median survival: 102 months versus 45 months; P < 0.001). Overall, 31% of patients had preoperative disease within the MC and 69% had preoperative disease beyond the MC. Estimated rates of recurrence-free survival at 5 years were 61.8% for all patients and 53.8% for patients with initial beyond-MC status. Independent factors for recurrence beyond-MC status included preoperative disease beyond the MC, the presence of microsatellite or multiple tumours and lymphovascular invasion (all: P < 0.001). A clinical risk score was used to predict survival and the likelihood of recurrence beyond the MC; patients with scores of 0, 1, 2 and 3 had 5- year incidence of recurring beyond-MC of 9.0%, 29.5%, 48.8% and 75.4%, respectively (P < 0.0001). CONCLUSIONS Regardless of initial MC status, at 5 years the majority of patients remained disease-free or experienced recurrence within the MC after LR, and thus were potentially eligible for salvage transplantation (ST). Incorporating clinicopathological parameters into the MC allows for better risk stratification, which improves the selection of patients for ST and identifies patients in need of closer surveillance.

[1]  Zhouying Zheng,et al.  Liver Transplantation Versus Liver Resection in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies , 2014, Transplantation.

[2]  T. Chua,et al.  Clinical efficacy and predictors of outcomes of repeat hepatectomy for recurrent hepatocellular carcinoma - a systematic review. , 2013, Surgical oncology.

[3]  Han‐Chieh Lin,et al.  Milan Criteria, Multi-nodularity, and Microvascular Invasion Predict the Recurrence Patterns of Hepatocellular Carcinoma After Resection , 2013, Journal of Gastrointestinal Surgery.

[4]  Carolyn Phillips,et al.  Use and Dissemination of the Brisbane 2000 Nomenclature of Liver Anatomy and Resections , 2013, Annals of surgery.

[5]  C. Hughes,et al.  Primary liver transplantation vs liver resection followed by transplantation for transplantable hepatocellular carcinoma: Liver functional quality and tumor characteristics matter. , 2013, World journal of gastrointestinal surgery.

[6]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[7]  R. DeMatteo,et al.  Resection versus transplantation for early hepatocellular carcinoma: more art than science. , 2012, Annals of surgery.

[8]  P. Chow,et al.  Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria , 2012, The British journal of surgery.

[9]  Lynette M. Smith,et al.  Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis. , 2012, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[10]  S. Todo,et al.  Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma , 2012, World Journal of Surgical Oncology.

[11]  V. Paradis,et al.  Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: An intention‐to‐treat analysis , 2012, Hepatology.

[12]  L. Mariani,et al.  Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence‐based analysis of 15 years of experience , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[13]  P. Chow,et al.  Microvascular Invasion Is a Better Predictor of Tumor Recurrence and Overall Survival Following Surgical Resection for Hepatocellular Carcinoma Compared to the Milan Criteria , 2011, Annals of surgery.

[14]  K. Lee Surgical Management of Hepatocellular Carcinoma (HCC) , 2010 .

[15]  Sung‐Gyu Lee,et al.  Liver transplantation and conventional surgery for advanced hepatocellular carcinoma , 2010, Transplant International.

[16]  B. Müllhaupt,et al.  Current and future trends in liver transplantation in Europe. , 2010, Gastroenterology.

[17]  A. Luciani,et al.  Liver Resection for Transplantable Hepatocellular Carcinoma: Long-Term Survival and Role of Secondary Liver Transplantation , 2009, Annals of surgery.

[18]  M. D'Angelica,et al.  Laparoscopic versus Open Liver Resection: A Matched-Pair Case Control Study , 2009, Journal of Gastrointestinal Surgery.

[19]  J. Marrero,et al.  An intention‐to‐treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[20]  M. Choti,et al.  Predictors of Survival After Resection of Early Hepatocellular Carcinoma , 2009, Annals of surgery.

[21]  S. Todo,et al.  Recurrence Patterns After Hepatectomy of Hepatocellular Carcinoma: Implication of Milan Criteria Utilization , 2009, Annals of Surgical Oncology.

[22]  L. Bolondi,et al.  Liver Transplantation for Hepatocellular Carcinoma: Results of Down‐Staging in Patients Initially Outside the Milan Selection Criteria , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[23]  Ana Casali,et al.  Hepatocellular carcinoma developed on compensated cirrhosis: Resection as a selection tool for liver transplantation , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[24]  M. Vivarelli,et al.  Liver Transplantation for Recurrent Hepatocellular Carcinoma on Cirrhosis After Liver Resection: University of Bologna Experience , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  M. Kattan,et al.  A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma. , 2008, Journal of the American College of Surgeons.

[26]  R. Lencioni,et al.  Treatment before Liver Transplantation for HCC , 2008, Annals of Surgical Oncology.

[27]  P. Majno,et al.  Management of hepatocellular carcinoma on the waiting list before liver transplantation: Time for controlled trials? , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[28]  P. Angeli,et al.  Intention‐to‐Treat Analysis of Liver Transplantation in Selected, Aggressively Treated HCC Patients Exceeding the Milan Criteria , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  T. Davern,et al.  A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[30]  V. Mazzaferro,et al.  Resection, transplantation, either, or both? Other pieces of the puzzle , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[31]  K. Hanazaki,et al.  Risk factors of long-term survival and recurrence after curative resection of hepatocellular carcinoma. , 2005, Hepato-gastroenterology.

[32]  J. Bruix,et al.  High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: An indication for salvage liver transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[33]  W. Jarnagin,et al.  Predictors and patterns of recurrence after resection of hepatocellular carcinoma. , 2003, Journal of the American College of Surgeons.

[34]  S. Fan,et al.  Long-Term Survival and Pattern of Recurrence After Resection of Small Hepatocellular Carcinoma in Patients With Preserved Liver Function: Implications for a Strategy of Salvage Transplantation , 2002, Annals of surgery.

[35]  P. Majno,et al.  Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: An outcome‐oriented decision analysis , 2000, Hepatology.

[36]  J. Bruix,et al.  Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation , 1999, Hepatology.

[37]  G. Mentha,et al.  Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost‐effectiveness perspective , 1998, Hepatology.

[38]  ndrea,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[39]  P. Bossuyt,et al.  Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. , 2012, The Lancet. Oncology.

[40]  L. Mariani,et al.  Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. , 2009, The Lancet. Oncology.